AURA vs MRNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Apr 04, 2026
AURA
57.1
AI Score
VS
It's a Tie!
MRNA
57.1
AI Score
Investment Advisor Scores
MRNA
57score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | AURA | MRNA | Winner |
|---|---|---|---|
| Net Income | -106.19M | -2.82B | AURA |
| Operating Income | -112.79M | -3.07B | AURA |
| ROE | -77.6% | -32.6% | MRNA |
| ROA | -62.7% | -22.9% | MRNA |
| Total Assets | 169.43M | 12.34B | MRNA |
| Cash | 59.52M | 2.60B | MRNA |
| Current Ratio | 8.15 | 3.29 | AURA |
| Free Cash Flow | -85.19M | -2.06B | AURA |
Frequently Asked Questions
Based on our detailed analysis, AURA and MRNA are evenly matched, both winning 4 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.